Fintel reports that on March 11, 2025, Goldman Sachs upgraded their outlook for GE HealthCare Technologies (NasdaqGS:GEHC) ...

Goldman Sachs upgrades GE Healthcare to Buy, raising its price target to $100, as analysts see market stabilization and China ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $104.0, a high estimate of $110.00, and a low estimate of $100.00. Observing a 9.76 ...

Goldman Sachs upgraded GE HealthCare (GEHC) to Buy from Neutral with a price target of $100, up from $85. The firm’s confidence in the outlook ...

The medical equipment manufacturer has tapped a longtime leader in China's health care environment to ease the transition ...

Value-based care provider Monogram Health is teaming with Memorial Hermann Health Plan to provide in-home services to chronically ill patients covered under the insurer’s commercial and Medicare ...

Yihao Zhang, GE HealthCare’s president and CEO for China, plans to retire, effective July 1. The company picked Will Song, a ...

Shares of GE HealthCare Technologies Inc. GEHC advanced 1.37% to $86.58 Friday, on what proved to be an all-around favorable ...

Shares of GE HealthCare Technologies Inc. GEHC slid 1.41% to $85.36 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 2.70% to ...

LOUISVILLE, Ky., February 13, 2025--(BUSINESS WIRE)--Humana and Monogram Health are pleased to announce a significant expansion, extending member access to in-home treatment for kidney disease and ...

In a report released today, Joanne Wuensch from Citi reiterated a Buy rating on GE Healthcare Technologies Inc (GEHC – Research Report). The ...

Humana and Monogram Health are pleased to announce ... and medication therapy management to transform the way health care is delivered for those with polychronic conditions. This innovative ...